The National Institute on Drug Abuse (NIDA) will award $3 million for research on developing medications to help treat individuals with addictions to multiple substances, including alcohol, tobacco, prescription drugs and illicit drugs.

The Medications Development for Polydrug Addiction Treatment grants will be made under the R01 and R21 research funding protocols. "Novel proposals for clinical or preclinical testing of potential medications, as well as relevant animal model development and medicinal chemistry efforts are encouraged," according to NIDA.

Four to seven grants are expected to be made.

Applications will be accepted on an ongoing basis. Eligible applicants include nonprofits, schools, governments, and others. For more information, see the grant announcements at the links above.